May Tun Saung

Assistant Professor

20122019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where May Tun Saung is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 1 Similar Profiles
Pancreatic Neoplasms Medicine & Life Sciences
Nanoparticles Medicine & Life Sciences
T-Lymphocytes Medicine & Life Sciences
Adenocarcinoma Medicine & Life Sciences
Myeloid Cells Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Tumor Microenvironment Medicine & Life Sciences
Immunomodulation Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2012 2019

Dissecting the stromal signalingandregulation of myeloid cells and memory effector T cells in pancreatic cancer

Blair, A. B., Kim, V. M., Muth, S. T., Saung, M. T., Lokker, N., Blouw, B., Armstrong, T. D., Jaffee, E. M., Tsujikawa, T., Coussens, L. M., He, J., Burkhart, R. A., Wolfgang, C. L. & Zheng, L., Sep 1 2019, In : Clinical Cancer Research. 25, 17, p. 5351-5363 13 p.

Research output: Contribution to journalArticle

Myeloid Cells
Pancreatic Neoplasms
Adenocarcinoma
T-Lymphocytes
Hyaluronic Acid

Physical and chemical profiles of nanoparticles for lymphatic targeting

Ke, X., Howard, G. P., Tang, H., Cheng, B., Saung, M. T., Santos, J. L. & Mao, H. Q., Jan 1 2019, (Accepted/In press) In : Advanced Drug Delivery Reviews.

Research output: Contribution to journalReview article

Nanoparticles
Lymphoid Tissue
Hydrophobic and Hydrophilic Interactions
Particle Size
Immunotherapy

Small molecule immunomodulation: The tumor microenvironment and overcoming immune escape

Osipov, A., Saung, M. T., Zheng, L. & Murphy, A. G., Aug 22 2019, In : Journal for immunotherapy of cancer. 7, 1, 224.

Research output: Contribution to journalReview article

Open Access
Tumor Microenvironment
Immunomodulation
Immunotherapy
Focal Adhesion Protein-Tyrosine Kinases
Neoplasms

Targeting myeloid-inflamed tumor with anti-CSF-1R antibody expands CD137+ effector T-cells in the murine model of pancreatic cancer

Saung, M. T., Muth, S., Ding, D., Thomas, D. L., Blair, A. B., Tsujikawa, T., Coussens, L., Jaffee, E. M. & Zheng, L., Nov 13 2018, In : Journal for ImmunoTherapy of Cancer. 6, 1, 1 p.

Research output: Contribution to journalArticle

Pancreatic Neoplasms
T-Lymphocytes
Antibodies
Adenocarcinoma
Neoplasms

Current Standards of Chemotherapy for Pancreatic Cancer

Saung, M. T. & Zheng, L., 2017, (Accepted/In press) In : Clinical Therapeutics.

Research output: Contribution to journalArticle

Pancreatic Neoplasms
Combination Drug Therapy
Drug Therapy
gemcitabine
Phase III Clinical Trials